Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401265
Status:
COMPLETED
Last Update Posted:
2024-05-06
First Post:
2024-05-02
Brief Title:
Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer UTUC
Sponsor:
Taipei Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation
Organization:
Taipei Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation
Study Overview
Official Title:
Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer UTUC
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Among urothelial cancers upper urinary tract urothelial cancers including renal pelvis and ureteral cancers have a higher incidence rate in Taiwan than Western countries In particular the proportion of female patients is similar to that of males This situation is significantly different from that in foreign countries The cause is currently uncertainIn the past the arsenic contamination of groundwater made blackfoot disease become common and malignant in areas Now the number of kidney dialysis patients in Taiwan is increasing and according to statistics there is a significantly higher incidence of urothelial cancer among kidney dialysis patients This may be caused by the use of traditional Chinese medicine or other unknown reasons
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None